(Q35647786)

9 August 2017

1 reference

title

Pharmacogenetics and anticoagulant therapy (English)

1 reference

9 August 2017

1 reference

1 reference

Brian F Gage

1

1 reference

9 August 2017

Charles S Eby

series ordinal

2

1 reference

9 August 2017

language of work or name

1 reference

1 August 2003

1 reference

Journal of Thrombosis and Thrombolysis

9 August 2017

published in

1 reference

9 August 2017

volume

16

1 reference

9 August 2017

issue

1-2

1 reference

9 August 2017

page(s)

73-78

1 reference

https://scigraph.springernature.com/pub.10.1023/b:thro.0000014598.24114.62

9 August 2017

exact match

0 references

cites work

A gene-anchored map position of the rat warfarin-resistance locus, Rw, and its orthologs in mice and humans.

1 reference

12 December 2020

Managing oral anticoagulant therapy

1 reference

12 December 2020

The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism

1 reference

12 December 2020

Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe

1 reference

12 December 2020

The influence of age, liver size and enantiomer concentrations on warfarin requirements

1 reference

12 December 2020

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

12 December 2020

Risk factors for bleeding in patients taking coumarins.

1 reference

12 December 2020

Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy

1 reference

12 December 2020

A new regimen for starting warfarin therapy in out-patients

1 reference

12 December 2020

Locus-specific genetic differentiation at Rw among warfarin-resistant rat (Rattus norvegicus) populations

1 reference

12 December 2020

Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism. A randomized, double-blind, controlled trial.

1 reference

12 December 2020

Prediction of the risk of bleeding during anticoagulant treatment for venous thromboembolism

1 reference

12 December 2020

Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention

1 reference

12 December 2020

Aging and the anticoagulant response to warfarin therapy

1 reference

12 December 2020

Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin

1 reference

12 December 2020

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

1 reference

12 December 2020

Factors affecting the maintenance dose of warfarin

1 reference

12 December 2020

Age as a determinant of sensitivity to warfarin

1 reference

12 December 2020

Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infarction patients

1 reference

12 December 2020

Warfarin resistance: diagnosis and therapeutic alternatives.

1 reference

12 December 2020

A comparison of a low-dose warfarin induction regimen with the modified Fennerty regimen in elderly inpatients.

1 reference

12 December 2020

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

12 December 2020

Flexible induction dose regimen for warfarin and prediction of maintenance dose

1 reference

12 December 2020

Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin

1 reference

12 December 2020

Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy

1 reference

12 December 2020

Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database

1 reference

12 December 2020

Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences

1 reference

12 December 2020

Natural selection mapping of the warfarin-resistance gene

1 reference

12 December 2020

Comparison of an age adjusted warfarin loading protocol with empirical dosing and Fennerty's protocol.

1 reference

12 December 2020

Genetic modulation of oral anticoagulation with warfarin

1 reference

12 December 2020

Interindividual variability in sensitivity to warfarin--Nature or nurture?

1 reference

12 December 2020

Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study

1 reference

12 December 2020

A major gene controlling warfarin-resistance in the house mouse

1 reference

12 December 2020

Assessment of an age-adjusted warfarin initiation protocol

1 reference

12 December 2020

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial

1 reference

12 December 2020

Genetic association between sensitivity to warfarin and expression of CYP2C9*3

1 reference

12 December 2020

A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial

1 reference

12 December 2020

Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation

1 reference

12 December 2020

Warfarin, aspirin, or both after myocardial infarction

1 reference

12 December 2020

Linkages between Genes for Coat Colour and Resistance to Warfarin in Rattus norvegicus

1 reference

12 December 2020

Assessing the cost-effectiveness of pharmacogenomics

1 reference

12 December 2020

Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin Optimized Outpatient Follow-up Study Group

1 reference

12 December 2020

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

1 reference

12 December 2020

Determinants of the response to coumarin anticoagulants in patients with acute myocardial infarction

1 reference

12 December 2020

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

1 reference

12 December 2020

Factors affecting warfarin requirements. A prospective population study

1 reference

12 December 2020

Population pharmacokinetics of racemic warfarin in adult patients

1 reference

12 December 2020

Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: genetic analysis of the CYP2C9 locus

1 reference

12 December 2020

Management and dosing of warfarin therapy

1 reference

12 December 2020

CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians

1 reference

12 December 2020

The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin

1 reference

12 December 2020

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

1 reference

12 December 2020

Genetic polymorphism in exon 4 of cytochrome P450 CYP2C9 may be associated with warfarin sensitivity in Chinese patients

1 reference

12 December 2020

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

1 reference

12 December 2020

Patient-specific factors predictive of warfarin dosage requirements

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

Identification and functional characterization of a new CYP2C9 variant (CYP2C9*5) expressed among African Americans

1 reference

12 December 2020

Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing

1 reference

12 December 2020

Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy

1 reference

12 December 2020

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

1 reference

12 December 2020

Evaluation of warfarin initiation regimens in elderly inpatients

1 reference

12 December 2020

Comparisons between in-vitro and in-vivo metabolism of (S)-warfarin: catalytic activities of cDNA-expressed CYP2C9, its Leu359 variant and their mixture versus unbound clearance in patients with the corresponding CYP2C9 genotypes

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

10.1023/B:THRO.0000014598.24114.62

Identifiers

DOI

1 reference

Dimensions Publication ID

9 August 2017

1034946568

0 references

1 reference